PA SB408 | 2019-2020 | Regular Session

Status

Spectrum: Partisan Bill (Republican 9-0)
Status: Introduced on March 11 2019 - 25% progression, died in committee
Action: 2019-03-11 - Referred to JUDICIARY
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [PDF]

Summary

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Further providing for drug overdose response immunity.

Sponsors


History

DateChamberAction
2019-03-11SenateReferred to JUDICIARY

Pennsylvania State Sources


Bill Comments

LegiScan Search

View Top 50 Searches

Select area of search.
Find an exact bill number.
Search bill text and data. [help]
Reset

LegiScan Trends

View Top 50 National

CA AB1113 California Longitudinal Pupil Achievement Data System: expanded learning...
NJ S3538 Establishes "Equitable Drug Pricing and Patient Access Act."
CA SB1315 School accountability: local educational agencies: annual reporting re...
CA AB2130 Parking violations.
CA AB1991 Licensee and registrant renewal: National Provider Identifier.
US HB10040 GARD Act Gift Accountability, Reporting, and Disclosures Act
CA AB2424 Mortgages: foreclosure.
LA SB8 Provides for legislative continuances. (Item #20) (gov sig)
NH HB1661 Relative to immunization reporting requirements.
CA AB2565 School facilities: interior locks.
feedback